The safety and efficacy of elective percutaneous coronary intervention using bivalirudin versus heparin and glycoprotein IIb/IIIa inhibitors: Insight from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium

被引:0
|
作者
Gurm, H [1 ]
Smith, DE [1 ]
Khanal, S [1 ]
Riba, A [1 ]
Carter, AJ [1 ]
LaLonde, T [1 ]
Kline-Rogers, EM [1 ]
Moscucci, M [1 ]
机构
[1] Univ Michigan, Med Ctr, Ann Arbor, MI USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:45B / 46B
页数:2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF BIVALIRUDIN VERSUS HEPARIN PLUS GLYCOPROTEIN IIB/IIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: A META-ANALYSIS OF RANDOMISED TRIALS
    Jiang Long
    Cheng Xiaoshu
    Yang Renqiang
    Fan Yingli
    Zhan Rui
    Hu Lijuan
    HEART, 2013, 99 : A72 - A72
  • [42] READMISSION AND LONG-TERM MORTALITY IN OLDER PATIENTS TREATED WITH TICAGRELOR VERSUS PRASUGREL AFTER PERCUTANEOUS CORONARY INTERVENTION: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
    Sukul, Devraj
    Seth, Milan
    Dupree, James M.
    Khandelwal, Akshay
    Dixon, Simon
    Wohns, David
    LaLonde, Thomas
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 1020 - 1020
  • [43] Risk of Acute Kidney Injury After Percutaneous Coronary Interventions Using Radial Versus Femoral Vascular Access Insights From the Blue Cross Blue Shield of Michigan Cardiovascular Consortium
    Kooiman, Judith
    Seth, Milan
    Dixon, Simon
    Wohns, David
    LaLonde, Thomas
    Rao, Sunil V.
    Gurm, Hitinder S.
    CIRCULATION-CARDIOVASCULAR INTERVENTIONS, 2014, 7 (02) : 190 - +
  • [44] OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION AMONG PATIENTS WITH A HISTORY OF TRANSIENT ISCHEMIC ATTACK OR CEREBROVASCULAR ACCIDENT: INSIGHTS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
    Sukul, Devraj
    Seth, Milan
    Wohns, David
    Dixon, Simon
    Slocum, Nicklaus
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 987 - 987
  • [45] Primary percutaneous coronary intervention at centers with and without on-site surgical support: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
    Afana, Majed
    Gurm, Hitinder S.
    Seth, Milan
    Frazier, Kathleen M.
    Fielding, Sheryl
    Koenig, Gerald C.
    AMERICAN HEART JOURNAL, 2018, 195 : 99 - 107
  • [46] ATRIAL FIBRILLATION IS A STRONG AND INDEPENDENT PREDICTOR OF POOR OUTCOME AMONG PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: FINDINGS FROM THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM
    Sutton, Nadia
    Seth, Milan
    Ruwende, Cyril
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2015, 65 (10) : A32 - A32
  • [47] Comprehensive Meta-Analysis of Safety and Efficacy of Bivalirudin Versus Heparin With or Without Routine Glycoprotein IIb/IIIa Inhibitors in Patients With Acute Coronary Syndrome
    Navarese, Eliano Pio
    Schulze, Volker
    Andreotti, Felicita
    Kowalewski, Mariusz
    Kolodziejczak, Michalina
    Kandzari, David E.
    Rassaf, Tienush
    Gorny, Bartosz
    Brockmeyer, Maximilian
    Meyer, Christian
    Berti, Sergio
    Kubica, Jacek
    Kelm, Malte
    Valgimigli, Marco
    JACC-CARDIOVASCULAR INTERVENTIONS, 2015, 8 (01) : 201 - 213
  • [48] The Comparative Effectiveness and Safety of Impella Versus Intra-Aortic Balloon Pump in Patients who Underwent Percutaneous Coronary Intervention: Insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2)
    Sukul, Devraj
    Seth, Milan
    Khandelwal, Akshay
    Hanzel, George
    Madder, Ryan
    Yamasaki, Hiroshi
    Changezi, Hameem
    Earl, Thomas
    Gurm, Hitinder
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 72 (13) : B36 - B36
  • [49] BIVALIRUDIN WITH PROVISIONAL GLYCOPROTEIN IIB/IIIA INHIBITORS COMPARED TO HEPARIN WITH PLANNED OR PROVISIONAL GLYCOPROTEIN IIB/IIIA INHIBITORS IN PATIENTS UNDERGOING PERCUTANEOUS CORONARY INTERVENTION: NETWORK META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS
    Patel, Tarpan R.
    Ivanov, Alexander
    Sacchi, Terrence
    Heitner, John
    Brener, Sorin
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 67 (13) : 199 - 199
  • [50] PERCUTANEOUS VASCULAR INTERVENTION MARKET TRENDS: BULLISH ON LEGS, BEARISH ON RENALS-THE BLUE CROSS BLUE SHIELD OF MICHIGAN CARDIOVASCULAR CONSORTIUM EXPERIENCE
    Thomas, Michael P.
    Park, Yeo Jung
    Schreiber, Theodore
    Gurm, Hitinder
    Leffler, Dale
    Davis, Thomas
    Grossman, Paul
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (12) : A2104 - A2104